Introduction: Brain-derived neurotrophic factor (BDNF) has been involved in the pathogenesis of
bipolar mood disorder and in the mechanism of mood-normalizing action of lithium.
The aim of this study was to find a possible association between lithium prophylactic
effect in bipolar patients and two polymorphisms of BDNF gene. Methods: Eighty-eight patients (35 males, 53 females) with bipolar illness were studied. Duration
of lithium prophylaxis ranged between 5-27 years (mean 15 years). Three categories
of prophylactic lithium response were delineated: excellent responders (ER), partial
responders (PR) and non-responders (NR). All patients were genotyped for two polymorphisms
of BDNF gene: Val66Met and -270C/T. Results: The Val/Met genotype of Val66Met polymorphism occurred more frequently (p = 0.037)
and there was a trend for a higher incidence of Met allele (p = 0.076), in ER than
in NR. A trend for C/T genotype and T allele of -270C/T polymorphism was observed
to occur more frequently in ER than in NR (p = 0.057 and p = 0.065, respectively).
Conclusion: The data obtained suggest that polymorphism of BDNF gene may be connected with a
quality of lithium prophylaxis.
References
- 1
Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé A A.
Lithium treatment alters brain concentrations of nerve growth factor, brain-derived
neurotrophic factor and glial cell line-derived neurotrophic factor in rat model of
depression.
Int J Neuropsychopharmacol.
2003;
6
225-231
- 2
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N. et al .
Characterization of single-nucleotide polymorphisms in coding regions of human genes.
Nat Genet.
1999;
22
231-238
- 3
Egan M, Kojima M, Callicot J H, Goldberg T E, Kolachana B S, Bertolino A. et al .
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human
memory and hippocampal function.
Cell.
2003;
112
257-269
- 4
Fukumoto T, Morinobu S, Okamoto Y, Kahaya A, Yamawaki S.
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor
in the rat brain.
Psychopharmacology.
2001;
158
100-106
- 5
Geller B, Badner J A, Tillman R, Christian S L, Bolhofner K, Cook EH J r.
Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism
in children with a prepubertal and early adolescent bipolar disorder phenotype.
Am J Psychiatry.
2004;
161
1698-1700
- 6
Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang D M.
Lithium induces brain-derived neurotrophic factor and activities TrkB in rodent cortical
neurons: an essential step for neuroprotection against glutamate neurotoxicity.
Neuropharmacology.
2002;
43
1173-1179
- 7
Hashimoto K, Shimizu E, Iyo M.
Critical role of brain-derived neurotrophic factor in mood disorders.
Brain Res Brain Res Rev.
2004;
45
104-114
- 8
Holoubek G, Noldner M, Treiber K, Muller W E.
Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction
cascade.
Which effect matters most? Pharmacopsychiatry.
2004;
37 (Suppl 2)
S113-119
- 9
Hong C J, Huo S J, Yen F C, Tung C L, Pan G M, Tsai S J.
Association study of a brain-derived neurotrophic-factor genetic polymorphism and
mood disorders, age of onset and suicidal behavior.
Neuropsychobiology.
2003;
48
86-189
- 10
Jacobsen J P, Mork A.
The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on
brain-derived neurotrophic factor mRNA and protein expression in the rat brain and
the correlation to 5-HT and 5-HIAA levels.
Brain Res.
2004;
1024
183-192
- 11
Kunugi H, Ueki M, Otsuga M, Isse K, Hirasawa H, Kato N. et al .
A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated
with late-onset Alzheimer’s disease.
Mol Psychiatry.
2001;
6
83-86
- 12
Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T. et al .
No association between the Val66Met polymorphism of the brain-derived neurotrophic
factor gene and bipolar disorder in a Japanese population: a multicenter study.
Biol Psychiatry.
2004;
56
376-378
- 13
Lu B.
BDNF and activity-dependent synaptic modulation.
Learn Mem.
2003;
10
86-98
- 14
Manji H K, Zarate C A.
Molecular and cellular mechanism underlying mood stabilization in bipolar disorder:
implications for the development of improved therapeutics.
Mol Psychiatry.
2002;
7
S1-S7
- 15
Miller S A, Dykaes D D, Polesky H F.
A simple salting out procedure for extracting DNA from human nucleated cells.
Nucleic Acid Res.
1988;
16
1215
- 16
Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T. et al .
Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar
disorder.
Neurosci Lett.
2003;
337
17-20
- 17
Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy J L.
The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder:
evidence from a family-based association study.
Am J Hum Genet.
2002;
71
651-655
- 18
Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C. et al .
Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar
affective disorder: a Belgian patient-control study.
Am J Med Genet.
2004;
129B
34-35
- 19
Proschel M, Saunders A, Roses A D, Muller C R.
Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic
factor (BDNF).
Hum Mol Genet.
1992;
1
353
- 20
Rowe M K, Chuang D M.
Lithium neuroprotection: molecular mechanisms and clinical implications.
Expert Rev Mol Med.
2004;
6
1-18
- 21
Rybakowski J K, Borkowska A, Czerski P M, Skibińska M, Hauser J.
Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive
prefrontal test in bipolar patients.
Bipolar Disord.
2003;
5
468-472
- 22 Rybakowski J K, Suwalska A, Czerski P M, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A,
Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related
to serotonin transporter genotype. Pol J Pharmacol 2004: (in press)
- 23
Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E.
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
Pharmacogenomics J.
2001;
1
71-77
- 24
Siuciak J A, Lewis D R, Wiegand S J, Lindsay R M.
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
Pharmacol Biochem Behav.
1997;
56
131-137
- 25
Skibińska M, Hauser J, Czerski P M, Leszczyńska-Rodziewicz A, Kosmowska M, Kapelski P.
et al .
Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism
in schizophrenia and bipolar affective disorder.
World J Biol Psychiatry.
2004;
5
215-220
- 26
Sklar P, Gabriel S B, McInnis M G, Bennet P, Lim Y M, Tsan G. et al .
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is
a potential risk locus.
Mol Psychiatry.
2002;
7
579-593
- 27
Strauss J, Barr C L, George C J, King N, Shaikh S, Devlin B. et al .
Association study of brain-derived neurotrophic factor in adults with a history of
childhood onset mood disorder.
Am J Med Genet..
2004;
131B
16-19
- 28 Szczepankiewicz A, Skibinska M, Czerski P M, Kapelski P, Leszczynska-Rodziewicz A,
Slopien A. et al .No association of the Brain-Derived Neurotrophic Factor (BDNF)
gene C-270T polymorphism with schizophrenia. Schizophr Res 2005: (in press)
- 29
Tsai S -J, Hong C -J, Yu Y W-Y, Chen T -J.
Association study of a brain-derived neurotrophic factor (BDNF) Val66met polymorphism
and personality trait and intelligence in healthy young females.
Neuropsychobiol.
2004;
49
13-16
- 30
Turecki G, Grof P, Grof E, D’Souza V, Lebuis L, Marineau C. et al .
Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based
on excellent response to lithium.
Mol Psychiatry.
2001;
6
570-578
- 31
Tyler W J, Alonso M, Bramham C R, Pozzo-Miller L D.
From acquisition to consolidation: on the role of brain-derived neurotrophic factor
signaling in hippocampal-dependent learning.
Learn Mem.
2002;
9
224-237
- 32
Yamada K, Mizuno M, Nabeshima T.
Role for brain-derived neurotrophic factor in learning and memory.
Life Sci.
2002;
70
735-744
Prof. Dr. Janusz K. Rybakowski
Department of Adult Psychiatry
University of Medical Sciences
ul.Szpitalna 27/33
60-572 Poznan
Poland
Phone: +48 61 8475 087
Fax: +48 61 8480 392
Email: rybakows@wlkp.top.pl